13 false false false false false false false false false false true false false false false false false No description of principal activity 2023-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 755,000 755,000 755,000 5,550 2,926 585 3,511 2,039 2,624 xbrli:pure xbrli:shares iso4217:GBP 11156985 2023-04-01 2024-03-31 11156985 2024-03-31 11156985 2023-03-31 11156985 2022-04-01 2023-03-31 11156985 2023-03-31 11156985 2022-03-31 11156985 core:NetGoodwill 2023-04-01 2024-03-31 11156985 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 11156985 bus:Director1 2023-04-01 2024-03-31 11156985 core:PlantMachinery 2023-03-31 11156985 core:PlantMachinery 2024-03-31 11156985 core:WithinOneYear 2024-03-31 11156985 core:WithinOneYear 2023-03-31 11156985 core:ShareCapital 2024-03-31 11156985 core:ShareCapital 2023-03-31 11156985 core:RetainedEarningsAccumulatedLosses 2024-03-31 11156985 core:RetainedEarningsAccumulatedLosses 2023-03-31 11156985 core:PlantMachinery 2023-04-01 2024-03-31 11156985 core:NetGoodwill 2023-03-31 11156985 core:NetGoodwill 2023-03-31 11156985 core:PlantMachinery 2023-03-31 11156985 bus:SmallEntities 2023-04-01 2024-03-31 11156985 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 11156985 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 11156985 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 11156985 bus:FullAccounts 2023-04-01 2024-03-31 11156985 bus:OrdinaryShareClass1 2024-03-31 11156985 bus:OrdinaryShareClass1 2023-03-31
COMPANY REGISTRATION NUMBER: 11156985
Balfour Road Surgery Limited
Filleted Unaudited Financial Statements
31 March 2024
Balfour Road Surgery Limited
Statement of Financial Position
31 March 2024
2024
2023
Note
£
£
£
£
Fixed assets
Intangible assets
5
755,000
Tangible assets
6
2,039
2,624
-------
---------
2,039
757,624
Current assets
Stocks
1,250
1,250
Debtors
7
218,801
Cash at bank and in hand
83,634
150,776
---------
---------
303,685
152,026
Creditors: amounts falling due within one year
8
131,551
813,525
---------
---------
Net current assets/(liabilities)
172,134
( 661,499)
---------
---------
Total assets less current liabilities
174,173
96,125
---------
--------
Capital and reserves
Called up share capital
9
100
100
Profit and loss account
174,073
96,025
---------
--------
Shareholders funds
174,173
96,125
---------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Balfour Road Surgery Limited
Statement of Financial Position (continued)
31 March 2024
These financial statements were approved by the board of directors and authorised for issue on 28 March 2025 , and are signed on behalf of the board by:
Dr S Sinha
Director
Company registration number: 11156985
Balfour Road Surgery Limited
Notes to the Financial Statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 146 New London Road, Chelmsford, Essex, CM2 0AW, England.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Goodwill
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 13 (2023: 13 ).
5. Intangible assets
Goodwill
£
Cost
At 1 April 2023
755,000
Additions
Disposals of previously acquired businesses
( 755,000)
---------
At 31 March 2024
---------
Amortisation
At 1 April 2023 and 31 March 2024
---------
Carrying amount
At 31 March 2024
---------
At 31 March 2023
755,000
---------
6. Tangible assets
Plant and machinery
£
Cost
At 1 April 2023 and 31 March 2024
5,550
-------
Depreciation
At 1 April 2023
2,926
Charge for the year
585
-------
At 31 March 2024
3,511
-------
Carrying amount
At 31 March 2024
2,039
-------
At 31 March 2023
2,624
-------
7. Debtors
2024
2023
£
£
Trade debtors
218,801
---------
----
8. Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
24,045
Corporation tax
42,624
Director loan accounts
755,000
Other creditors
64,882
58,525
---------
---------
131,551
813,525
---------
---------
9. Called up share capital
Issued, called up and fully paid
2024
2023
No.
£
No.
£
Ordinary shares of £ 1 each
100
100
100
100
----
----
----
----